Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 13, 2016 - Issue 2
Submit an article Journal homepage
268
Views
36
CrossRef citations to date
0
Altmetric
Original Research

Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers

Aziz MalekiZanjan Pharmaceutical Nanotechnology Research Center (ZPNRC), Zanjan University of Medical Sciences, Zanjan, Iran
&
Mehrdad HamidiZanjan Pharmaceutical Nanotechnology Research Center (ZPNRC), Zanjan University of Medical Sciences, Zanjan, IranCorrespondence[email protected]
Pages 171-181 | Received 18 Jun 2015, Accepted 30 Sep 2015, Published online: 04 Dec 2015

Bibliography

  • Papers of special note have been highlighted aseither of interest (•) or of considerable interest (••) to readers.
  • Takagi T, Ramachandran C, Bermejo M, et al. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm. 2006;3:631–643.
  • Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420:1–10.

●● A mini review on the various approaches developed for the enhancement of solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs.

  • Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharmaceutics Biopharmaceutics. 2000;50:47–60.
  • Argyo C, Weiss V, Bräuchle C, et al. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater. 2013;26:435–451.
  • Colilla M, González B, Vallet-Regí M. Mesoporous silica nanoparticles for the design of smart delivery nanodevices. Biomater Sci. 2013;1:114–134.
  • Lee JE, Lee N, Kim T, et al. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res. 2011;44:893–902.
  • Wang Y, Zhao Q, Hu Y, et al. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica. Int J Nanomedicine. 2013;8:4015–4031.
  • Slowing II, Trewyn BG, Giri S, et al. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater. 2007;17:1225–1236.
  • Liu J, Li C, Li F. Fluorescence turn-on chemodosimeter-functionalized mesoporous silica nanoparticles and their application in cell imaging. J Mater Chem. 2011;21:7175–7181.
  • Salinas AJ, Esbrit P, Vallet-Regí M. A tissue engineering approach based on the use of bioceramics for bone repair. Biomater Sci. 2013;1:40–51.
  • Ehlert N, Mueller PP, Stieve M, et al. Mesoporous silica films as a novel biomaterial: applications in the middle ear. Chem Soc Rev. 2013;42:3847–3861.
  • Xu W, Riikonen J, Lehto V-P. Mesoporous systems for poorly soluble drugs. Int J Pharm. 2013;453:181–197.

●● A review describing the use of mesoporous systems, including porous silica- and silicon-based materials in dissolution enhancement of poorly soluble drugs.

  • Asefa T, Tao Z. Biocompatibility of mesoporous silica nanoparticles. Chem Res Toxicol. 2012;25:2265–2284.
  • Wang Y, Sun L, Jiang T, et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Drug Dev Ind Pharm. 2013;40:819–828.
  • Zhang Y, Jiang T, Zhang Q, et al. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property. Eur J Pharmaceutics Biopharmaceutics. 2010;76:17–23.
  • Shen S-C, Ng WK, Chia L, et al. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int J Pharm. 2011;410:188–195.
  • Jia L, Shen J, Li Z, et al. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs. Int J Pharm. 2012;439:81–91.
  • Hu Y, Wang J, Zhi Z, et al. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J Colloid Interface Sci. 2011;363:410–417.
  • Zhu W, Wan L, Zhang C, et al. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Mater Sci Engineering: C. 2014;34:78–85.
  • Mellaerts R, Aerts CA, Van Humbeeck J, et al. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. Chem Commun. 2007;13:1375–1377.
  • Kumar D, Sailaja Chirravuri S, Shastri NR. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac. Int J Pharm. 2014;461:459–468.
  • Sun L, Wang Y, Jiang T, et al. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol. ACS Appl Mater Interfaces. 2012;5:103–113.
  • Martín A, García R, Karaman DS, et al. Polyethyleneimine-functionalized large pore ordered silica materials for poorly water-soluble drug delivery. J Mater Sci. 2014;49:1437–1447.
  • Zhang Y, Zhi Z, Jiang T, et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Controlled Release. 2010;145:257–263.
  • Ahern RJ, Hanrahan JP, Tobin JM, et al. Comparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug delivery. Eur J Pharm Sci. 2013;50:400–409.
  • Limnell T, Santos HA, Mäkilä E, et al. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci. 2011;100:3294–3306.
  • Khanfar M, Fares MM, Salem M, et al. Mesoporous silica based macromolecules for dissolution enhancement of irbesartan drug using pre-adjusted pH method. Microporous Mesoporous Mater. 2013;173:22–28.
  • Waters LJ, Hussain T, Parkes G, et al. Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation. Eur J Pharmaceutics Biopharmaceutics. 2013;85:936–941.
  • Wu X, Whitfield LR, Stewart BH. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm Res. 2000;17:209–215.
  • Law MR, Wald NJ, Rudnicka A. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326:1423.
  • Lennernäs H. Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet. 2003;42:1141–1160.
  • Anwar M, Warsi MH, Mallick N, et al. Enhanced bioavailability of nano-sized chitosan–atorvastatin conjugate after oral administration to rats. Eur J Pharm Sci. 2011;44:241–249.
  • Shen H, Zhong M. Preparation and evaluation of self‐microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2006;58:1183–1191.

● It describes that SMEDDS enhanced oral bioavailability of poorly water-soluble drug, atorvastatin.

  • Kim J-S, Kim M-S, Park HJ, et al. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. Int J Pharm. 2008;359:211–219.
  • Kim M-S, Jin S-J, Kim J-S, et al. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharmaceutics Biopharmaceutics. 2008;69:454–465.
  • Horcajada P, Ramila A, Perez-Pariente J, et al. Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater. 2004;68:105–109.
  • Qu F, Zhu G, Huang S, et al. Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater. 2006;92:1–9.
  • Heikkilä T, Salonen J, Tuura J, et al. Mesoporous silica material TUD-1 as a drug delivery system. Int J Pharm. 2007;331:133–138.

● This is the first example of the feasibility of siliceous mesoporous material TUD-1 for dissolution enhancement of poorly soluble drug ibuprofen.

  • Zhao D, Huo Q, Feng J, et al. Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc. 1998;120:6024–6036.
  • Schmidt-Winkel P, Lukens WW, Zhao D, et al. Mesocellular siliceous foams with uniformly sized cells and windows. J Am Chem Soc. 1999;121:254–255.
  • Van Speybroeck M, Mellaerts R, Mols R, et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur J Pharm Sci. 2010;41:623–630.
  • Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133.

●● An excellent review that describes the use of quantitative analysis for the values obtained in dissolution/release tests.

  • Sadighi A, Ostad S, Rezayat S, et al. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer. Int J Pharm. 2012;422:479–488.
  • Barzegar-Jalali M. Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci. 2008;11:167–177.
  • Khan K. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–49.
  • Asare-Addo K, Šupuk E, Al-Hamidi H, et al. Triboelectrification and dissolution property enhancements of solid dispersions. Int J Pharm. 2015;485:306–316.
  • Sevimli F, Yılmaz A. Surface functionalization of SBA-15 particles for amoxicillin delivery. Microporous Mesoporous Mater. 2012;158:281–291.
  • Zhang H-X, Wang J-X, Zhang Z-B, et al. Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm. 2009;374:106–113.
  • Hu Y, Zhi Z, Zhao Q, et al. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous Mesoporous Mater. 2012;147:94–101.
  • Zhang Y, Zhang J, Jiang T, et al. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties. Int J Pharm. 2011;410:118–124.
  • Yang P, Quan Z, Lu L, et al. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials. 2008;29:692–702.
  • Vo CL-N, Park C, Lee B-J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharmaceutics Biopharmaceutics. 2013;85:799–813.
  • Guo Z, Liu X-M, Ma L, et al. Effects of particle morphology, pore size and surface coating of mesoporous silica on naproxen dissolution rate enhancement. Colloids Surf B: Biointerfaces. 2013;101:228–235.
  • Popova MD, Szegedi Á, Kolev IN, et al. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers. Int J Pharm. 2012;436:778–785.
  • Azadi A, Hamidi M, Rouini M-R. Methotrexate-loaded chitosan nanogels as ‘Trojan Horses’ for drug delivery to brain: preparation and in vitro/in vivo characterization. Int J Biol Macromol. 2013;62:523–530.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.